Baxter (NYSE: BAX) reported Q3 EPS of $1.02, $0.08 better than the analyst estimate of $0.94. Revenue for the quarter came in at $3.2 billion versus the consensus estimate of $3.23 billion.

GUIDANCE:

Baxter sees Q4 2021 EPS of $1.00-$1.04, versus the consensus of $1.02.

• For fourth-quarter 2021: The company expects sales growth of 3% to 4% on a reported basis, 4% to 5% on a constant currency basis and 3% to 4% on an operational basis. The company expects U.S. GAAP earnings of $0.75 to $0.79 per diluted share and adjusted earnings, before special items, of $1.00 to $1.04 per diluted share.

For earnings history and earnings-related data on Baxter (BAX) click here.